中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Tremelimumab AstraZeneca
    Tremelimumab AstraZeneca
    departments：肿瘤科
    drug：注射液
    Active：Tremelimumab
    indication：非小细胞肺癌
    Licensor：AstraZeneca AB
    Approved Country/Region：EMA
    Approval time：2023-02-20